• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia

Trendingnow

1

Current price of oil as of June 17, 2026

2

'Work hard, stay loyal, and the system will reward you': the Boomer credo is a Gen X betrayal and a Millennial pipe dream

3

Hundreds of Stanford students walked out of their grad ceremony to protest Google CEO’s commencement speech. It wasn’t all about AI

1

Current price of oil as of June 17, 2026

2

'Work hard, stay loyal, and the system will reward you': the Boomer credo is a Gen X betrayal and a Millennial pipe dream

3

Hundreds of Stanford students walked out of their grad ceremony to protest Google CEO’s commencement speech. It wasn’t all about AI
Health

Leading South African COVID scientist accuses West of racism over skeptical response to country’s Omicron research

By
David Meyer
David Meyer
Down Arrow Button Icon
By
David Meyer
David Meyer
Down Arrow Button Icon
January 21, 2022, 8:15 AM ET
Add Fortune on Google for similar content.

A senior South African scientist has accused Western nations of racism, over the way they skeptically received early data from the country showing that the Omicron variant of the novel coronavirus is relatively mild.

Shabir Madhi—professor of vaccinology at the University of the Witwatersrand, chair of the National Advisory Group on Immunization, and a top World Health Organization adviser—told the BBC that the West had at the least refused “to believe the science because it came from Africa.”

“It seems like high-income countries are much more able to absorb bad news that comes from countries like South Africa,” he said. “When we’re providing good news, all of a sudden there’s a whole lot of skepticism. I would call that racism.”

Madhi was one of the prominent South African experts telling the world in early December that Omicron was fast-spreading but had what seemed to be a low hospitalization rate. The country’s scientists continued to emit such data throughout that month, before a formal South African study—and two others from the U.K.—confirmed Omicron’s mildness. Within a couple weeks, rich countries’ leaders started talking about treating Omicron like the flu, though the WHO continues to warn against being so blasé about the variant.

Some of the early skepticism referenced the potentially confounding effects of South Africa’s relatively young population; younger people are generally less likely to get serious ill with COVID. However, Madhi pointed out that South Africans are actually more susceptible to severe disease, because of the prevalence of HIV and high obesity rates there. (Indeed, South African scientists were noting from the start that Omicron was having a milder impact on older people as well as younger.)

“Scientifically rigorous”

Salim Karim, the South African vice-president of the International Science Council, also told the BBC that “everyone was expecting the worst [about Omicron] and when they weren’t seeing it, they were questioning whether our observations were sufficiently scientifically rigorous.”

As it happens, South Africa has excellent laboratory infrastructure, largely thanks to the decades it has spent fighting HIV and tuberculosis, among other viruses and diseases.

A few months after the pandemic struck, the government tapped into this infrastructure by establishing a new network of labs, scientists and academics to sequence samples and provide scientific data in the COVID-19 fightback. A Regional Centre of Excellence for Genomic Surveillance and Bioinformatics was set up last July, to support the rapid expansion of sequencing across the whole of southern Africa.

African COVID vaccine production is already leaning heavily on South Africa, due to the advanced state of its biotech sector, though more capacity is likely to come online in Senegal this year.

South Africa’s genomic-sequencing prowess has certainly proved useful. It identified the Beta variant in late 2020 and Omicron a year later, after scientists there and in neighboring Botswana discovered the new strain at the same time. (Botswanan President Mokgweetsi Masisi subsequently said his country’s first cases were foreign diplomats who had come from Europe.)

“Vaccine apartheid”

But the reaction to these discoveries also prompted rich countries to institute travel bans on the region, decimating tourism and hammering currencies. This reaction was widely characterized as racist—and ineffective.

“When South African scientists discovered Omicron, the new variant, they immediately took on the responsibility of informing the entire world that a new variant has been found,” President Cyril Ramaphosa said last month. “And what was the response? The northern countries decided to punish the excellence from Africa. They basically said, we will not allow you to travel. Lo and behold! Omicron is spreading all over the world.”

The South African leader also slammed rich countries over their hoarding of vaccines, claiming they were fueling “vaccine apartheid”—a reference to the racist system of “separate development” that heavily oppressed South African Black people in the days of white minority rule.

“They are just giving us the crumbs from their table. The greed they demonstrated was disappointing, particularly when they say they are our partners. Because our lives in Africa are just as important as lives in Europe, North America and all over,” Ramaphosa said.

Never miss a story: Follow your favorite topics and authors to get a personalized email with the journalism that matters most to you.

About the Author
By David Meyer
LinkedIn icon
See full bioRight Arrow Button Icon
Add Fortune on Google for similar content.

Latest in Health

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Health

The froyopocalypse is over. Gen Z is swarming frozen yogurt shops like it’s 2010
RetailGen Z
The froyopocalypse is over. Gen Z is swarming frozen yogurt shops like it’s 2010
By Sam Klebanov and Morning BrewJune 17, 2026
8 hours ago
Needles used to detect breast cancer in shortage from recall
Healthbreast cancer
Needles used to detect breast cancer in shortage from recall
By Annika Inampudi, Anna Edney and BloombergJune 17, 2026
8 hours ago
Best Father’s Day Gifts (2026): Make Dad’s Day Special
HealthDietary Supplements
Best Father’s Day Gifts (2026): Make Dad’s Day Special
By Christina SnyderJune 17, 2026
9 hours ago
Abhinav Agarwal and Jenny Duan
Startups & VentureBiotech
Exclusive: A 21-year-old Stanford grad just raised $11 million to put a hormone lab on your wrist
By Lily Mae LazarusJune 17, 2026
16 hours ago
He fled Iran for the American Dream, became a millionaire, and could have retired—instead, he built the health tech that saved his father from cancer
SuccessFortune The Good Life
He fled Iran for the American Dream, became a millionaire, and could have retired—instead, he built the health tech that saved his father from cancer
By Orianna Rosa RoyleJune 17, 2026
22 hours ago
‘It’s on us’: Luigi Mangione’s hearing delayed after DA failed to request him from jail
Lawcourts
‘It’s on us’: Luigi Mangione’s hearing delayed after DA failed to request him from jail
By Michael R. Sisak and The Associated PressJune 16, 2026
2 days ago

Most Popular

Current price of oil as of June 17, 2026
Personal Finance
Current price of oil as of June 17, 2026
By Joseph HostetlerJune 17, 2026
16 hours ago
'Work hard, stay loyal, and the system will reward you': the Boomer credo is a Gen X betrayal and a Millennial pipe dream
Success
'Work hard, stay loyal, and the system will reward you': the Boomer credo is a Gen X betrayal and a Millennial pipe dream
By Nick LichtenbergJune 16, 2026
2 days ago
Hundreds of Stanford students walked out of their grad ceremony to protest Google CEO’s commencement speech. It wasn’t all about AI
Big Tech
Hundreds of Stanford students walked out of their grad ceremony to protest Google CEO’s commencement speech. It wasn’t all about AI
By Tristan BoveJune 15, 2026
3 days ago
Exclusive: Universal beat Disney as Hollywood's maker of the most expensive movie of all time 
Arts & Entertainment
Exclusive: Universal beat Disney as Hollywood's maker of the most expensive movie of all time 
By Christian SyltJune 17, 2026
18 hours ago
Current price of oil as of June 16, 2026
Personal Finance
Current price of oil as of June 16, 2026
By Joseph HostetlerJune 16, 2026
2 days ago
Melinda French Gates' advice to new IPO millionaires: 'Give half your money away'
Startups & Venture
Melinda French Gates' advice to new IPO millionaires: 'Give half your money away'
By Emma HinchliffeJune 13, 2026
5 days ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.